Voyageur Pharmaceuticals Ltd. (TSXV:VM)
0.105
0.00 (0.00%)
Apr 28, 2026, 2:45 PM EST
Voyageur Pharmaceuticals Revenue
Voyageur Pharmaceuticals had revenue of 19.27K CAD in the quarter ending February 28, 2026. This brings the company's revenue in the last twelve months to 30.96K. In the fiscal year ending November 30, 2025, Voyageur Pharmaceuticals had annual revenue of 11.69K.
Revenue (ttm)
30.96K
Revenue Growth
n/a
P/S Ratio
608.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
18.84M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ayr Wellness | 650.97M |
| Avicanna | 25.48M |
| Greenway Greenhouse Cannabis | 9.13M |
| 1CM Inc. | 75.01M |
| Red Light Holland | 4.17M |
| Red White & Bloom Brands | 70.97M |
| Crescita Therapeutics | 21.12M |
| Mountain Valley MD Holdings | 57.00K |
Voyageur Pharmaceuticals News
- 11 days ago - Voyageur Announces Shares for Debt Settlement and Stock Option Repricing - TheNewswire
- 4 weeks ago - Voyageur Announces Non-Brokered Life Offering - TheNewswire
- 6 weeks ago - Voyageur Announces Advancements on its Barium & Iodine Contrast Media Projects - TheNewswire
- 7 weeks ago - Voyageur Pharmaceuticals Confirms Pharmaceutical-Grade Purity of Barite from Frances Creek and Progresses to Health Canada Human Trial with Alberta Innovates Grant; Announces Stock Option and DSU grants, and Proposed Issuance of Securities for Debt - TheNewswire
- 2 months ago - Voyageur Pharmaceuticals Announces Collaboration with Bayer - TheNewswire
- 3 months ago - Voyageur Pharmaceuticals Strengthens Scientific Team by Adding Dr. Brian Mueller as Director of Chemistry and Secures Exclusive Ownership of Iodine Extraction Technology - TheNewswire
- 6 months ago - Voyageur Pharmaceuticals Ltd. Strengthens Board of Directors with Seasoned Financial Executive Virginia Alling to Drive U.S. Market Expansion - TheNewswire
- 6 months ago - Voyageur Pharmaceuticals Signs Non-Exclusive Distribution & Wholesale Agreement with PHALANX - TheNewswire